Harbor Capital Advisors’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$797K Buy
25,398
+13,488
+113% +$569K 0.05% 412
2026
Q1
$659K Sell
11,910
-320
-3% -$15.2K 0.05% 420
2025
Q4
$457K Buy
12,230
+1,641
+15% +$66.7K 0.04% 510
2025
Q3
$428K Buy
10,589
+704
+7% +$23.3K 0.03% 521
2025
Q2
$252K Sell
9,885
-928
-9% -$20.2K 0.01% 590
2025
Q1
$231K Buy
10,813
+10,589
+4,727% +$237K 0.01% 606
2024
Q4
$5K Buy
224
+57
+34% +$1.32K ﹤0.01% 1134
2024
Q3
$4K Buy
+167
New +$3.23K ﹤0.01% 1184

Other funds holding PAHC

Harbor Capital Advisors's PAHC Position: Q2 2026 in Review

Harbor Capital Advisors increased its Phibro Animal Health (PAHC) stake by 113% in Q2 2026, buying an estimated $569K and bringing the position to 25,398 shares worth $797K. The position accounts for 0.05% of the portfolio, ranked #412.

Harbor Capital Advisors first reported a position in PAHC in Q3 2024 and has held it in 8 quarters since. 92 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Harbor Capital Advisors held 25,398 shares of Phibro Animal Health worth $797K as of Q2 2026.
  • Harbor Capital Advisors bought 13,488 Phibro Animal Health shares in Q2 2026, an estimated $569K.
  • Phibro Animal Health made up 0.05% of Harbor Capital Advisors's portfolio in Q2 2026, its #412 holding.
  • Harbor Capital Advisors first reported a position in Phibro Animal Health in Q3 2024 and has held it in 8 quarters since.
  • 92 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.